中国循证医学杂志
中國循證醫學雜誌
중국순증의학잡지
CHINESE JOURNAL OF EVIDENCE-BASED MEDICINE
2010年
4期
441-443
,共3页
何晓俐%康淑琼%龚成英%姜光瑶
何曉俐%康淑瓊%龔成英%薑光瑤
하효리%강숙경%공성영%강광요
甲流疫苗%接种%不良反应
甲流疫苗%接種%不良反應
갑류역묘%접충%불량반응
Influenza%A H1N1 vaccine%Vaccination%Adverse event reaction
目的 观察分析接种国产甲型H1N1流感疫苗者的安全性.方法 按照集中自愿的原则,对我院3 300例医务工作者接种上海生物制品有限公司生产、批号为200909012的甲型H1N1流感疫苗,并观察其接种后不良反应,包括接种半小时内、3天内和1周内不良反应例数及表现症状.结果 3 300例接种H1N1流感疫苗者中,有自觉不适或全身不良反应者占1.18%(39/3 300).接种疫苗后半小时内出现不适者占0.15%(5/3 300)接种疫苗后1~3天后出现不适者占0.70%(23/3 300);接种疫苗后3天至1周内出现不适者占0.33%(11/3 300).无严重不良反应发生.结论 国产甲型H1N1流感疫苗不良反应发生较少,其安全性可靠,是目前预防甲型H1N1较经济有效的手段之一.
目的 觀察分析接種國產甲型H1N1流感疫苗者的安全性.方法 按照集中自願的原則,對我院3 300例醫務工作者接種上海生物製品有限公司生產、批號為200909012的甲型H1N1流感疫苗,併觀察其接種後不良反應,包括接種半小時內、3天內和1週內不良反應例數及錶現癥狀.結果 3 300例接種H1N1流感疫苗者中,有自覺不適或全身不良反應者佔1.18%(39/3 300).接種疫苗後半小時內齣現不適者佔0.15%(5/3 300)接種疫苗後1~3天後齣現不適者佔0.70%(23/3 300);接種疫苗後3天至1週內齣現不適者佔0.33%(11/3 300).無嚴重不良反應髮生.結論 國產甲型H1N1流感疫苗不良反應髮生較少,其安全性可靠,是目前預防甲型H1N1較經濟有效的手段之一.
목적 관찰분석접충국산갑형H1N1류감역묘자적안전성.방법 안조집중자원적원칙,대아원3 300례의무공작자접충상해생물제품유한공사생산、비호위200909012적갑형H1N1류감역묘,병관찰기접충후불량반응,포괄접충반소시내、3천내화1주내불량반응례수급표현증상.결과 3 300례접충H1N1류감역묘자중,유자각불괄혹전신불량반응자점1.18%(39/3 300).접충역묘후반소시내출현불괄자점0.15%(5/3 300)접충역묘후1~3천후출현불괄자점0.70%(23/3 300);접충역묘후3천지1주내출현불괄자점0.33%(11/3 300).무엄중불량반응발생.결론 국산갑형H1N1류감역묘불량반응발생교소,기안전성가고,시목전예방갑형H1N1교경제유효적수단지일.
Objective To investigate safety of influenza A H1N1 vaccine vaccinations.Methods A total of 3 300 medical workers were vaccinated by batch of 200909012 influenza A H1N1 vaccine produced by Shanghai Biological Products Corporation Limited according to the principle of voluntary and concentration.The adverse reactions were observed within half an hour,three days and a week after vaccinations,respectively.Results The inoculators with local or systemic reaction reached 1.18% (39/3 300).There were 0.15% (5/3 300) of the inoculators with adverse reaction within half an hour;0.70% (23/3 300) within 1 to 3 days after vaccination;and 0.33% (11/3 300) within 3 days to 1 week after vaccination.No severe adverse events were found.Conclusion Influenza A H1N1 vaccine vaccinations is an economic and effective way of influenza A H1N1 prevention with mild reactions.